Decreasing mRNA levels of AGTR1, GCKR, GCLC, CD14, CYP2E1, NR1I2, PPARA, PNPLA3 and TM6SF2 and increasing expression of PARVB were associated with progression from normal liver to HCC (high confidence observations). Here, NR1I2 is linked to hepatocellular carcinoma.